Gene · 8239
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transketolase-like 1 potentiates PD-1 blockade in hepatocellular carcinoma by glycolysis to prime dendritic cell lactylation. | Signal Transduct Target Ther | 2026 | 42802226 | PubTator, text mining | PubMed |
| Interactions Between E3 Ubiquitin Ligases and Deubiquitinases in AKT Regulation: Implications in Skeletal Muscle Homeostasis. | Cell Biochem Funct | 2026 | 42671015 | PubTator, text mining | PubMed |
| Atractylenolide I alleviates LPS-induced pulmonary cell injury relevant to pediatric pneumonia via the ERK/USP9X/Mcl-1 and Akt/Survivin axes. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 42624927 | PubTator, text mining | PubMed |
| Palmitoylation of TK1 exacerbates osteoarthritis by promoting JNK-mediated metabolic reprogramming. | Proc Natl Acad Sci U S A | 2026 | 42546205 | PubTator, text mining | PubMed |
| Insufficiency of cohesin regulatory protein PDS5B triggers meiotic failure and aneuploidy in oocytes during advanced maternal aging. | Proc Natl Acad Sci U S A | 2026 | 42531021 | PubTator, text mining | PubMed |
| The Deubiquitinating Enzyme USP9X Regulates the Protein Stability of the FAM49B in Clear Cell Renal Cell Carcinoma. | J Proteome Res | 2026 | 42463156 | PubTator, text mining | PubMed |
| Bioinformatics screening identifies USP9X as a pathogenic gene underlying thyroid and breast cancer comorbidity. | J Mol Histol | 2026 | 42417888 | PubTator, text mining | PubMed |
| USP9X trims STAT1 to curb oncostatin M activity and intestinal inflammation. | Cell Mol Immunol | 2026 | 42350601 | PubTator, text mining | PubMed |
| HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation-Mediated TXNRD1 Stabilization to Suppress Ferroptosis. | Cancer Res | 2026 | 42314062 | PubTator, text mining | PubMed |
| Recurrent COPA mutation drives R-spondin-independent Wnt activation in intestinal tumors. | Nat Genet | 2026 | 42286202 | PubTator, text mining | PubMed |
| Faf1 accelerates p97-mediated protein unfolding by promoting ubiquitin engagement. | Cell Rep | 2026 | 42228561 | PubTator, text mining | PubMed |
| Macrophage USP9X attenuates colitis by restricting oncostatin M production via K27-linked deubiquitination of STAT1. | Cell Mol Immunol | 2026 | 42209766 | PubTator, text mining | PubMed |
| USP9X Promotes Hepatocellular Carcinoma Progression via Stabilization of HSP90AA1. | J Hepatocell Carcinoma | 2026 | 42153130 | PubTator, text mining | PubMed |
| Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile. | J Pathol | 2026 | 42138099 | PubTator, text mining | PubMed |
| Sirtuin 7-mediated deacetylation of hypoxia-inducible factor 1-alpha facilitates glycolytic reprogramming and inflammation of keratinocytes in psoriasis. | J Adv Res | 2026 | 41985670 | PubTator, text mining | PubMed |
| The Ubiquitin-proteasome system in neuroinflammation and neurodegeneration: Molecular insights and therapeutic avenues. | Int Immunopharmacol | 2026 | 41967208 | PubTator, text mining | PubMed |
| Global analysis of cancer cell responses to USP9X inhibition. | EMBO J | 2026 | 41946992 | PubTator, text mining | PubMed |
| HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies. | Cancer Discov | 2026 | 41925564 | PubTator, text mining | PubMed |
| Clinical and Genetic Characteristics of a Chinese Occult Maculopathy Cohort. | Transl Vis Sci Technol | 2026 | 41891770 | PubTator, text mining | PubMed |
| Case Report: De novo USP9X missense mutation in a male fetus with pulmonary atresia and ventricular septal defect: expanding the genotype-phenotype spectrum of USP9X-related disorders. | Front Cardiovasc Med | 2026 | 41884638 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8239/papers